Sof marja: curis.com (CRIS)

Curis (CRIS) grafik logotipi

Curis, Inc. avtomatlashtirilgan birikmalarni skrining qilishga tayanadi, klinik sinovlarning barcha bosqichlarini esa tashqi CRO tarmoqlariga autsorsing qiladi. Konsolidatsiyalashgan sof savdo marjasi ushbu tuzilmaning natijasini aks ettiradi, bunda -1893.20 ushbu ko'rsatkichning darajasini ko'rsatadi. Jori dinamika emavasertibning leykoz terapiyasidagi muvaffaqiyati, FDA maqomlariga erishilishi va yirik sog'liqni saqlash gigantlari tomonidan sotib olinish imkoniyati bilan qo'llab-quvvatlanmoqda.

CRIS: curis.com Sof foyda normasi 04.07.2022 - 19.11.2026

curis.com (CRIS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Curis, CRIS
Curis, Inc. ishlab chiqargan mahsulot

Curis, Inc. maqsadli onkologik dori vositalarining intensiv klinik sinovlariga e'tibor qaratadi. Operatsion sof marja daromaddan barcha xarajatlar chegirib tashlanganidan keyin kompaniyada qolgan foyda ulushini ko'rsatadi. Ushbu hisob-kitob intellektual kapitalni monetizatsiya qilish samaradorligini baholash imkonini beradi. Operatsion sof marja tendentsiyasi R&D xarajatlari va daromadlar o'rtasidagi muvozanatni aks ettiradi. Investorlar uchun ushbu ko'rsatkichni aktivlarning tartibga soluvchi tasdiqlash bosqichlari bilan bog'lash juda muhimdir.

Curis, Inc. (CRIS) raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)